Pulmonx Corporation Share Price
NASDAQ: LUNG | Micro CapPulmonx Corporation Stock Performance
Open $2.28 | Prev. Close $2.27 | Circuit Range N/A |
Day Range $2.25 - $2.32 | Year Range $1.14 - $2.88 | Volume 35,083 |
Average Traded $2.28 |
Pulmonx Corporation Share Price Today
As of 13 August 2026, Pulmonx Corporation's share price is $2.30. The stock opened at $2.28, compared to its previous close of $2.27. During today's trading session, Pulmonx Corporation's share price traded between $2.25 and $2.32, with an average price of $2.29. Over the past 52 weeks, the stock has recorded a high of $2.88 and a low of $1.14. In terms of performance, Pulmonx Corporation's share price has risen by 45.57% over the last six months and is up 34.50% on a year-on-year basis.
Pulmonx Corporation Share Price Chart
Pulmonx Corporation Stock Fundamentals & Key Indicators
Market Cap $93.58M | PE Ratio (TTM) -1.73 | Dividend Yield N/A |
EPS (TTM) $-1.33 | Revenue (TTM) $90.50M | Return On Equity (TTM) -99.79% |
Profit Margin -59.67% | Debt to Equity 0.37 | Quarterly Earnings Growth YoY 1.32% |
Pulmonx Corporation Quarterly Profit & Loss
All figures in USD
Pulmonx Corporation Annual Profit & Loss
All figures in USD
About Pulmonx Corporation
Pulmonx Corporation, a commercial-stage medical technology company that provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease. It offers Zephyr Endobronchial Valve; and Chartis Pulmonary Assessment System, a balloon catheter and console system with flow and pressure sensors that are used to assess the presence of collateral ventilation. The company also offers LungTraX Platform, a cloud-based quantitative computed tomography analysis service that provides physicians with multiple products, such as LungTraX Connect to improve workup efficiency; LungTraX Detect to enable patient identification; and StratX Lung report that is designed for solution that includes information on emphysema destruction, fissure completeness, and lobar volume to help identify target lobes for treatment with Zephyr Valves. It serves emphysema patients in the United States, Europe, the Middle East, Africa, the Asia Pacific, and internationally. The company was formerly known as Pulmonx and changed its name to Pulmonx Corporation in December 2013. Pulmonx Corporation was incorporated in 1995 and is headquartered in Redwood City, California.
Pulmonx Corporation Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Aug 2026 | $1.71 | $2.30 | +41.98% |
Jul 2026 | $1.30 | $1.62 | +25.10% |
Jun 2026 | $1.64 | $1.29 | -21.99% |
May 2026 | $1.34 | $1.66 | +29.69% |
Apr 2026 | $1.30 | $1.28 | -0.78% |
Mar 2026 | $1.49 | $1.29 | -18.35% |
Feb 2026 | $1.65 | $1.58 | -3.07% |
Jan 2026 | $2.21 | $1.63 | -26.24% |
Dec 2025 | $1.64 | $2.21 | +34.35% |
Nov 2025 | $2.02 | $1.65 | -17.96% |
Oct 2025 | $1.63 | $2.00 | +23.01% |
Sep 2025 | $1.64 | $1.63 | -4.68% |
LUNG Share Price FAQs
What is Pulmonx Corporation share price today?
What is the 52 week high and 52 week low of Pulmonx Corporation stock?
What is LUNG's market capitalisation today?
What is LUNG's net income for the last quarter?
What is the 5 year returns of LUNG?
What is the high & low stock price of LUNG today?
Can I buy LUNG shares in India?